Latest News from: Yale Cancer Center

Filters close
Newswise: Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
Released: 17-Jun-2021 1:15 PM EDT
Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
Yale Cancer Center

In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.

Newswise: Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
Released: 15-Jun-2021 12:05 PM EDT
Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
Yale Cancer Center

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Newswise: Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer
Released: 7-Jun-2021 6:40 PM EDT
Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer
Yale Cancer Center

A study led by researchers at Yale Cancer Center, Stony Brook University and KDx Diagnostics, Inc., examined a revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker, and revealed the test can detect the presence of new bladder cancer in patients with hematuria, or blood in the urine.

Newswise: Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
Released: 22-Apr-2021 4:30 PM EDT
Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
Yale Cancer Center

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income. The results were published online today in the Journal of Clinical Oncology (JCO).

Newswise: Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
19-Apr-2021 8:00 AM EDT
Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
Yale Cancer Center

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).

Newswise: Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
Released: 19-Apr-2021 9:00 AM EDT
Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
Yale Cancer Center

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumor DNA damage response.

Released: 5-Apr-2021 4:00 PM EDT
Researchers Identify Genes Behind Uterine Leiomyosarcoma Which May Be Treated Using Precision Medicine
Yale Cancer Center

In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS).

Newswise: Cecelia Calhoun Named Director of the Adolescent-Young Adult Sickle Cell Program at Yale Cancer Center and Smilow Cancer Hospital
Released: 23-Mar-2021 2:50 PM EDT
Cecelia Calhoun Named Director of the Adolescent-Young Adult Sickle Cell Program at Yale Cancer Center and Smilow Cancer Hospital
Yale Cancer Center

Cecelia Calhoun, MD, MSPH, MBA, has been appointed Assistant Professor of Medicine (Hematology) and Assistant Professor of Pediatrics (Hematology/Oncology) at Yale Cancer Center and Smilow Cancer Hospital

Newswise: Yale Study Shows Combined Liver–Cytokine Humanization Rescues Circulating Red Blood Cells for Testing of Novel Therapeutics
Released: 4-Mar-2021 4:35 PM EST
Yale Study Shows Combined Liver–Cytokine Humanization Rescues Circulating Red Blood Cells for Testing of Novel Therapeutics
Yale Cancer Center

In a new study by the Yale Department of Immunobiology and Yale Cancer Center, researchers report combined liver and growth factor humanization enhances human red blood cell production and survival in circulation the immunodeficient murine host.

Newswise: Yale Researchers Identify Tumor Reactive Immune-Cells to help fight against Advanced Melanoma
Released: 2-Mar-2021 10:00 AM EST
Yale Researchers Identify Tumor Reactive Immune-Cells to help fight against Advanced Melanoma
Yale Cancer Center

According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer. The findings were published today in the Journal of Experimental Medicine.

Newswise: Chênevert Family Brain Tumor Center Launched at Yale
Released: 25-Feb-2021 9:05 PM EST
Chênevert Family Brain Tumor Center Launched at Yale
Yale Cancer Center

Yale School of Medicine announces a gift to establish the Chênevert Family Brain Tumor Center at Yale Cancer Center. The Chênevert Family Brain Tumor Center will be a leading center in Neuro-Oncology research worldwide, bringing ground-breaking solutions and hope to patients with brain tumors.

Newswise: Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer Recurrence
Released: 23-Feb-2021 12:00 PM EST
Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer Recurrence
Yale Cancer Center

In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer.

Newswise: Maryam Lustberg Named Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center
Released: 19-Feb-2021 10:15 AM EST
Maryam Lustberg Named Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center
Yale Cancer Center

Maryam Lustberg, MD, MPH, has been appointed Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. She will also join the faculty at Yale Cancer Center as an Associate Professor of Medicine (Medical Oncology).

Newswise: Yale Cancer Center Study Shows Targeted Therapy Improves Survival for Advanced Bladder Cancer
12-Feb-2021 10:45 AM EST
Yale Cancer Center Study Shows Targeted Therapy Improves Survival for Advanced Bladder Cancer
Yale Cancer Center

In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.

Newswise: Researchers Discover Mechanism to Overcome Drug-Resistance in B-Cell Acute Lymphoblastic Leukemia
29-Jan-2021 9:00 AM EST
Researchers Discover Mechanism to Overcome Drug-Resistance in B-Cell Acute Lymphoblastic Leukemia
Yale Cancer Center

In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. The findings were published online today in the Proceedings of the National Academy of Sciences.

Newswise: Dr. Rachel Greenup Appointed Chief of Breast Surgical Oncology at Yale
Released: 25-Jan-2021 7:35 AM EST
Dr. Rachel Greenup Appointed Chief of Breast Surgical Oncology at Yale
Yale Cancer Center

Rachel Adams Greenup, MD, MPH, FACS, has been appointed as Associate Professor of Surgery (Oncology) and Section Chief of Breast Surgery for the Department of Surgery at Yale School of Medicine. In her new role, Dr. Greenup will provide breast surgical oncology leadership across the Smilow Cancer Hospital Network and Care Centers.

Newswise: Yale study leads to FDA approval of drug to treat non-small cell lung cancer
Released: 18-Dec-2020 3:40 PM EST
Yale study leads to FDA approval of drug to treat non-small cell lung cancer
Yale Cancer Center

Based on results of a clinical trial led by Yale Cancer Center researchers, the U.S. Food and Drug Administration has approved osimertinib for the treatment of adults with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations, which occurs in about 10 percent of patients.

Newswise: Roy S. Herbst, MD, PhD, Receives 2020 ACCC Clinical Research Award
Released: 17-Dec-2020 1:15 PM EST
Roy S. Herbst, MD, PhD, Receives 2020 ACCC Clinical Research Award
Yale Cancer Center

Roy S. Herbst, MD, PhD, Chief of Medical Oncology and Associate Cancer Center Director for Translational Research at Yale Cancer Center and Smilow Cancer Hospital, has been selected as the 2020 Clinical Research Award recipient by the Association of Community Cancer Centers for significantly and positively impacting oncology patients, their families, and the broader oncology community.

Newswise: Dr. Stephanie Halene Appointed Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital
Released: 7-Dec-2020 9:05 PM EST
Dr. Stephanie Halene Appointed Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital
Yale Cancer Center

Following an extensive national search, Stephanie Halene, MD, PhD, has been appointed Chief of Hematology at Yale Cancer Center, Smilow Cancer Hospital and the Yale School of Medicine Department of Internal Medicine.

Newswise: Yale Cancer Center Study Shows Caplacizumab Not Cost Effective for Rare Blood Disorder
Released: 7-Dec-2020 11:55 AM EST
Yale Cancer Center Study Shows Caplacizumab Not Cost Effective for Rare Blood Disorder
Yale Cancer Center

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

Newswise: Yale Cancer Center Study Shows Regional Variation in Genomic Testing for Men with Prostate Cancer
Released: 30-Nov-2020 8:05 AM EST
Yale Cancer Center Study Shows Regional Variation in Genomic Testing for Men with Prostate Cancer
Yale Cancer Center

In a new study by Yale Cancer Center, researchers found substantial regional variation in use of genomic testing for prostate cancer, raising questions about access and other factors that might promote rapid adoption of new cancer technologies.

Newswise: Smilow Cancer Hospital Receives CT Lions Eye Research Foundation Grant to Study Eye Cancer
Released: 13-Nov-2020 9:55 AM EST
Smilow Cancer Hospital Receives CT Lions Eye Research Foundation Grant to Study Eye Cancer
Yale Cancer Center

The Connecticut Lions Eye Research Foundation has awarded a grant to Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center.

Newswise: Researchers Uncover New Mechanism of Immune-Cell Activation
4-Nov-2020 10:20 AM EST
Researchers Uncover New Mechanism of Immune-Cell Activation
Yale Cancer Center

In a new study by Yale Cancer Center, scientists have identified the short endosomal protein interferon-inducible transmembrane protein 3 or IFITM3 as a central amplifier to supercharge activation of immune cells.

Newswise: Dr. Michaela Dinan Named Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center
Released: 21-Oct-2020 12:55 PM EDT
Dr. Michaela Dinan Named Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center
Yale Cancer Center

Michaela A. Dinan, PhD, has been appointed Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center.

Newswise: Yale Cancer Center Receives NIH Grant to Fund COVID-19 Research in Patients with Hematologic Cancers
Released: 8-Oct-2020 1:35 PM EDT
Yale Cancer Center Receives NIH Grant to Fund COVID-19 Research in Patients with Hematologic Cancers
Yale Cancer Center

The National Institutes of Health has awarded a Research Project Cooperative Agreement grant to Yale Cancer Center.

Newswise: Yale Trial Validates Immunotherapy Treatment for Non-Small Cell Lung Cancer
28-Sep-2020 11:30 AM EDT
Yale Trial Validates Immunotherapy Treatment for Non-Small Cell Lung Cancer
Yale Cancer Center

The immunotherapy drug atezolizumab improves survival over standard chemotherapy for many patients with newly diagnosed non-small cell lung cancer, according to a new study led by Yale Cancer Center researchers.

Newswise: Yale Cancer Center Awarded NIH SPORE for Head and Neck Cancer Research
Released: 24-Sep-2020 4:50 PM EDT
Yale Cancer Center Awarded NIH SPORE for Head and Neck Cancer Research
Yale Cancer Center

Yale Cancer Center researchers were awarded a five-year, $11.7 million grant from the National Institutes of Health to fund the Yale Head and Neck Cancer Specialized Program of Research Excellence.

Newswise: Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC
Released: 21-Sep-2020 9:00 AM EDT
Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC
Yale Cancer Center

According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.

Newswise: Yale Cancer Center Receives NCI Grant Renewal to Fund Clinical Trials
Released: 15-Jul-2020 12:05 PM EDT
Yale Cancer Center Receives NCI Grant Renewal to Fund Clinical Trials
Yale Cancer Center

The National Cancer Institute has awarded a UM1 grant renewal to Yale Cancer Center. The 6-year, $3 million a year grant will fund early phase investigator-initiated clinical trials to develop new potential therapies for treating both solid tumors and hematologic malignancies.

Newswise: Dr. Marcella Nunez-Smith Named Director of Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital
Released: 10-Jul-2020 6:25 PM EDT
Dr. Marcella Nunez-Smith Named Director of Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital
Yale Cancer Center

Marcella Nunez-Smith, MD, MHS, has been appointed Director of the Center for Community Engagement and Health Equity for Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH), as well as Chief Health Equity Officer & Deputy Chief Medical Officer, at SCH, and Associate Cancer Center Director for Community Outreach and Engagement at YCC.

Newswise: Yale Cancer Center Awarded NIH SPORE Renewal for Lung Cancer Research
Released: 8-Jul-2020 9:05 PM EDT
Yale Cancer Center Awarded NIH SPORE Renewal for Lung Cancer Research
Yale Cancer Center

Yale Cancer Center researchers were awarded a $11 million grant renewal from the National institutes of Health to fund the Yale Specialized Program of Research Excellence (SPORE) in Lung Cancer.

Newswise: Müschen Named Inaugural Director of Center of Molecular and Cellular Oncology at Yale Cancer Center and Yale School of Medicine
Released: 8-Jul-2020 9:05 PM EDT
Müschen Named Inaugural Director of Center of Molecular and Cellular Oncology at Yale Cancer Center and Yale School of Medicine
Yale Cancer Center

Markus Müschen, M.D., Ph.D., has been named the inaugural Director of the Center of Molecular and Cellular Oncology at Yale Cancer Center and Smilow Cancer Hospital. Müschen will also be appointed Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology at Yale School of Medicine.

Newswise: Study Shows Breast Cancer Detected Earlier in States with Expanded Medicaid Coverage
28-Jun-2020 8:00 PM EDT
Study Shows Breast Cancer Detected Earlier in States with Expanded Medicaid Coverage
Yale Cancer Center

In a new study by Yale Cancer Center, researchers have demonstrated that in states with expanded Medicaid coverage through the Affordable Care Act (ACA) a higher percentage of women with breast cancer had their disease diagnosed at an early stage. No such change was seen in states that didn’t expand their coverage. The findings were published today in JAMA Surgery.

Newswise: Covid-19 Blood Clotting Cause Identified in Study
29-Jun-2020 1:15 PM EDT
Covid-19 Blood Clotting Cause Identified in Study
Yale Cancer Center

New findings led by Yale Cancer Center researchers and experts across several medical specialties at Yale identify a leading mechanism behind the pathophysiology of Covid-19 and pinpoint a biological marker for the mechanism that may aid in treating these patients.

Newswise: Study Validates Combination Therapy for Aggressive Endometrial Cancer
26-Jun-2020 12:45 PM EDT
Study Validates Combination Therapy for Aggressive Endometrial Cancer
Yale Cancer Center

Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.

Newswise: Yale Scientists Develop a New Experimental Method to Study Infection and Disease, Including COVID-19
8-Jun-2020 2:30 PM EDT
Yale Scientists Develop a New Experimental Method to Study Infection and Disease, Including COVID-19
Yale Cancer Center

Yale Cancer Center scientists have developed a new cell screening method for agents that alter biologic functions. This approach uses thousands of artificial proteins called “traptamers” and may help to answer research questions that are difficult to address with other cell screening methods, including the SARS-CoV-2 virus, COVID-19. The data is published today in the journal Cell Reports.

Newswise: Scientists Reveal How Mutations in Metabolism Can Drive Cancers
1-Jun-2020 12:15 PM EDT
Scientists Reveal How Mutations in Metabolism Can Drive Cancers
Yale Cancer Center

Yale Cancer Center scientists have identified mutations in metabolite-producing genes as a disruption of DNA repair. These mutation-driven “oncometabolites” may make cells more prone to developing cancer—but also more vulnerable to new cancer treatment strategies.

Newswise: Study Shows Clinical Evidence of Anti-Tumor Activity in Patients with Metastatic Castration-Resistant Prostate Cancer
Released: 29-May-2020 8:00 AM EDT
Study Shows Clinical Evidence of Anti-Tumor Activity in Patients with Metastatic Castration-Resistant Prostate Cancer
Yale Cancer Center

Results of a Phase I clinical trial conducted by researchers at the Yale Cancer Center have shown that ARV-110, an androgen receptor PROTAC® protein degrader, demonstrates anti-tumor responses in patients with metastatic castration-resistant prostate cancer.

Newswise:Video Embedded study-shows-profound-benefit-with-targeted-therapy-for-patients-with-early-stage-nsclc
VIDEO
28-May-2020 5:00 PM EDT
Study Shows Profound Benefit with Targeted Therapy for Patients with Early Stage NSCLC
Yale Cancer Center

According to findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery significantly improves disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations.

Newswise: Study Demonstrates Impact of Both Inherited and Acquired Mutations on Cancer
14-May-2020 2:45 PM EDT
Study Demonstrates Impact of Both Inherited and Acquired Mutations on Cancer
Yale Cancer Center

The common belief that tumors arise via activation of a few genes that “drive” cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center (YCC) researchers.

Newswise: Study Shows Immunotherapy Prior to Surgery May Help Destroy High-Risk Breast Cancer
27-Apr-2020 9:00 AM EDT
Study Shows Immunotherapy Prior to Surgery May Help Destroy High-Risk Breast Cancer
Yale Cancer Center

A new study led by Yale Cancer Center (YCC) researchers shows women with high-risk HER2-negative breast cancer treated before surgery with immunotherapy, plus a PARP inhibitor with chemotherapy, have a higher rate of complete eradication of cancer from the breast and lymph nodes compared to chemotherapy alone.

Newswise: Yale Cancer Center Announces Hematology Leadership Appointments
Released: 20-Apr-2020 8:35 AM EDT
Yale Cancer Center Announces Hematology Leadership Appointments
Yale Cancer Center

Yale Cancer Center announces the appointments of Thomas Prebet, M.D., Ph.D., as Disease Aligned Research Team (DART) Leader for Myeloid Malignancies and Amer Zeidan, MBBS, as Director of the Hematology Early Therapeutics Program.

Newswise: Study points to obesity as driver of pancreatic cancer
17-Apr-2020 8:20 AM EDT
Study points to obesity as driver of pancreatic cancer
Yale Cancer Center

A new study led by Yale Cancer Center (YCC) researchers has demonstrated in mice that hormones released from the pancreas itself can advance pancreatic cancer — and that weight loss can stop this process in its early stages. The research was published today in the journal Cell.

Newswise: First Test Using Immunotherapy Drug to Treat Advanced Lung Cancer Shows Benefit — And Future Promise
Released: 13-Apr-2020 8:40 AM EDT
First Test Using Immunotherapy Drug to Treat Advanced Lung Cancer Shows Benefit — And Future Promise
Yale Cancer Center

Researchers at Yale Cancer Center (YCC) have found that use of the checkpoint inhibitor pembrolizumab can extend life with very few side effects in this patient population.

Newswise: Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s
Released: 25-Mar-2020 9:35 AM EDT
Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s
Yale Cancer Center

There are substantial costs associated with breast cancer screenings for U.S. women in their 40s, a new Yale Cancer Center-led study finds, and these costs vary widely by region.

Newswise: Dr. Mehra Golshan Appointed Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center
Released: 24-Mar-2020 4:15 PM EDT
Dr. Mehra Golshan Appointed Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center
Yale Cancer Center

Mehra Golshan, M.D., M.B.A., F.A.C.S., has been appointed the inaugural Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center, Professor of Surgery at Yale School of Medicine, and Interim Director of the Breast Center at Smilow Cancer Hospital.

20-Feb-2020 12:40 PM EST
Yale Cancer Center Study Shows Long-Term Survival Benefit for Certain Patients with Advanced Lung Cancer
Yale Cancer Center

According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

Newswise: Lenox receives Yale Cancer Center Ruth McCorkle Oncology Advanced Practice Provider award
Released: 3-Feb-2020 11:40 AM EST
Lenox receives Yale Cancer Center Ruth McCorkle Oncology Advanced Practice Provider award
Yale Cancer Center

Raymond Lenox, APRN, was presented with the Yale Cancer Center Ruth McCorkle Oncology Advanced Practice Provider Award at YCC’s annual Conclave.

Newswise: Yan wins Yale Cancer Center Class of 1961 Cancer Research Award
Released: 3-Feb-2020 11:40 AM EST
Yan wins Yale Cancer Center Class of 1961 Cancer Research Award
Yale Cancer Center

Qin Yan, Ph.D., was presented with the Yale Cancer Center (YCC) Class of 1961 Cancer Research Award at YCC’s annual Conclave

Newswise: Yale Cancer Center presents Research awards during annual Conclave
Released: 3-Feb-2020 11:40 AM EST
Yale Cancer Center presents Research awards during annual Conclave
Yale Cancer Center

Yale Cancer Center (YCC) held its annual Conclave and award ceremony. The night celebrated the accomplishments of goals set for 2019 and honored faculty and staff with clinical and research prizes.


Showing results

150 of 289

close
0.21118